Leflunomide-an Immunomodulator-Induces Regression of Endometrial Explants in a Rat Model of Endometriosis

Journal of the Society for Gynecologic Investigation

Volumn 13, Issue 5, 2006, Pages 378-383

  Uygur, Dilek ^a   Aytan, Hakan ^b   Zergeroglu, Sema ^c   Batioglu, Sertaç ^c  

^a Education and Research Hospital   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c Chest Surgery Education and Research Hospital   (Turkey)

Author keywords

Endometriosis; immune modulators; leflunomide; rat model

Indexed keywords

IMMUNOMODULATING AGENT; LEFLUNOMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIUM; EVALUATION; EXPLANT; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE GROWTH; TUMOR REGRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; IMMUNOLOGIC FACTORS; ISOXAZOLES; RATS; RATS, WISTAR;

EID: 33745242316     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2006.03.006     Document Type: Article

References (48)

1. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-425
2. Strathy J.H., Molgaard C.A., Coulam C.B., and Melton L.J. Endometriosis and infertility. A laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 38 (1982) 667-672
3. Lebovic D.I., Mueller M.D., Hornung D., and Taylor R.N. Immunology of endometriosis. Immunol Allergy Clin North Am 22 (2002) 585-598
4. Bellehumeur C., Collette T., Maheux R., Mailloux J., Villeneuve M., and Akoum A. Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis. Hum Reprod 20 (2005) 1177-1184
5. Ho H.N., Wu M.Y., and Yang Y.S. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 38 (1997) 400-412
6. Wu M.Y., and Ho H.N. The role of cytokines in endometriosis. Am J Reprod Immunol 49 (2003) 285-296
7. D'Hooghe T.M., Nugent N.P., Cuneo S., et al. Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons. A prospective, randomized, placebo- and drug-controlled study. Biol Reprod 74 (2006) 131-136
8. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., and Caudle M.R. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 34 (1995) 381-385
9. Cao X., Yang D., Song M., Murphy A., and Parthasarathy S. The presence of endometrial cells in the peritoneal cavity enhances monocyte recruitment and induces inflammatory cytokines in mice. Implications for endometriosis. Fertil Steril 82 Suppl 3 (2004) 999-1007
10. Hornung D., Bentzien F., Wallwiener D., Kiesel L., and Taylor R.N. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod 7 (2001) 163-168
11. D'Antonio M., Martelli F., Peano S., Papoian R., and Borrelli F. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. J Reprod Immunol 48 (2000) 81-98
12. Barrier B.F., Bates G.W., Leland M.M., Leach D.A., Robinson R.D., and Propst A.M. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril 81 Suppl 1 (2004) 775-779
13. Nothnick W.B., Curry T.E., and Vernon M.W. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 31 (1994) 151-162
14. Ingelmo J.M., Quereda F., and Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model. Fertil Steril 71 (1999) 907-911
15. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., and Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72 (1999) 135-141
16. Hornung D., Chao V.A., Vigne J.L., Wallwiener D., and Taylor R.N. Thiazolidinedione inhibition of peritoneal inflammation. Gynecol Obstet Invest 55 (2003) 20-24
17. Lebovic D.I., Kir M., and Casey C.L. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 82 Suppl 3 (2004) 1008-1013
18. Rozman B. Clinical pharmacokinetics of leflunomide. Clin Pharmacokinet 41 (2002) 421-430
19. Breedveld F.C., and Dayer J.M. Leflunomide. Mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 59 (2000) 841-849
20. Manna S.K., and Aggarwal B.B. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. J Immunol 162 (1999) 2095-2102
21. Vernon M.W., and Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 (1985) 684-694
22. Chong A.S., Huang W., Liu W., et al. In vivo activity of leflunomide. Pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 68 (1999) 100-109
23. Jones R.C. The effect of a luteinizing hormone-releasing hormone antagonist on experimental endometriosis in the rat. Acta Endocrinol 114 (1987) 379-382
24. Halme J., Becker S., Hammond M.G., Raj M.H., and Raj S. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol 145 (1983) 333-337
25. Braun D.P., Muriana A., Gebel H., Rotman C., Rana N., and Dmowski W.P. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 61 (1994) 78-84
26. Leiva M.C., Hasty L.A., Pfeifer S., Mastroianni Jr. L., and Lyttle C.R. Increased chemotactic activity of peritoneal fluid in patients with endometriosis. Am J Obstet Gynecol 168 (1993) 592-598
27. Arici A., Oral E., Attar E., Tazuke S.I., and Olive D.L. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril 67 (1997) 1065-1072
28. Akoum A., Lemay A., Brunet C., Hebert J., and The Groupe d'Investigation en Gynecologie. Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. Am J Obstet Gynecol 172 (1995) 594-600
29. Taketani Y., Kuo T.M., and Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 167 (1992) 265-270
30. Lebovic D.I., Bentzien F., Chao V.A., Garrett E.N., Meng Y.G., and Taylor R.N. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod 6 (2000) 269-275
31. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 334 (1996) 1717-1725
32. Overton C., Fernandez-Shaw S., Hicks B., Barlow D., and Starkey P. Peritoneal fluid cytokines and the relationship with endometriosis and pain. Hum Reprod 11 (1996) 380-386
33. Richter O.N., Dorn C., Rosing B., Flaskamp C., and Ulrich U. Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis. Arch Gynecol Obstet 271 (2005) 143-147
34. Bedaiwy M.A., Goldberg J.M., Falcone T., et al. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Hum Reprod 17 (2002) 601-604
35. Arend W.P., and Dayer J.M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38 (1995) 151-160
36. Elder R.T., Xu X., Williams J.W., Gong H., Finnegan A., and Chong A.S. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol 159 (1997) 22-27
37. Murray B.E. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis 163 (1991) 1184-1194
38. Cutolo M., Sulli A., Ghiorzo P., Pizzorni C., Craviotto C., and Villaggio B. Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis 62 (2003) 297-302
39. Chong A.S., Rezai K., Gebel H.M., et al. Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. Transplantation 61 (1996) 140-145
40. Williams J.W., Xiao F., Foster P., et al. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation 57 (1994) 1223-1231
41. Bartlett R.R., Dimitrijevic M., Mattar T., et al. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Act 32 (1991) 10-21
42. Xu X., Shen J., Mall J.W., et al. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide. Mechanisms of action. Biochem Pharmacol 58 (1999) 1405-1413
43. Eckhardt S.G., Rizzo J., Sweeney K.R., et al. Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors. J Clin Oncol 17 (1999) 1095-1104
44. Aytan H., Uygur D., Mollamahmutoglu L., and Batioglu S. Prevention of adhesion formation with leflunomide. Human Reprod 20 Suppl 1 (2005) 67-68
45. Mladenovic V., Domljan Z., Rozman B., et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis Rheum 38 (1995) 1595-1603
46. Strand V., Cohen S., Schiff M., et al., Leflunomide Rheumatoid Arthritis Investigators Group. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159 (1999) 2542-2550
47. Brent R.L. Teratogen update: Reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 63 (2001) 106-112
48. Aytan H., Caglar P., Uygur D., Zergeroglu S., and Batioglu S. Effect of immunomodulator leflunomide in the induction of endometriosis in an experimental rat model. Europ J Obstet Gynecol 123 Suppl (2005) 56